2020
DOI: 10.1016/j.clon.2019.12.004
|View full text |Cite
|
Sign up to set email alerts
|

A Review of Modern Radiation Therapy Dose Escalation in Locally Advanced Head and Neck Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 39 publications
2
22
0
Order By: Relevance
“…Some previous studies have reported dose escalation using a VMAT technique in head and neck cancer ( 7 , 12 17 ). Lauve et al.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Some previous studies have reported dose escalation using a VMAT technique in head and neck cancer ( 7 , 12 17 ). Lauve et al.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, IIHDP VMAT could be more effective technique for improving local control of the tumors. Some previous studies have reported dose escalation using a VMAT technique in head and neck cancer (7,(12)(13)(14)(15)(16)(17). Lauve et al reported the results of the phase I trial of dose escalation to GTV in bulky HNSCC patients (12).…”
Section: Discussionmentioning
confidence: 99%
“…Radiation therapy (RT) is employed to cure localized cancers and is known to act both by killing malignant cells and by activating anti-tumor immune responses (Atwell et al, 2019(Atwell et al, , 2020Bellia et al, 2019;Fellin et al, 2019;Gupta and Chatterjee, 2020;Koukourakis and Giatromanolaki, 2020). Despite the wide use of RT to overcome the main problem of cancer resistance, the mechanisms by which radiations activate immune system to kill cancer cells are still under intense debate.…”
Section: Microfluidic Devices For Studying the Effects Of Radiations mentioning
confidence: 99%
“…These findings indicate that a better RT boost to TV is possible. The quantitative data provided by DW-MRI could reflect intratumoral heterogeneity, highlighting more radioresistant areas (14,15). Subsequently, elective dose escalation can be individually delivered to these areas.…”
Section: Diffusion-weighted Mrimentioning
confidence: 99%